ClinVar Miner

Submissions for variant NM_025193.4(HSD3B7):c.689A>G (p.Tyr230Cys)

gnomAD frequency: 0.00001  dbSNP: rs1020519659
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Neuberg Centre For Genomic Medicine, NCGM RCV001823615 SCV002073190 uncertain significance Congenital bile acid synthesis defect 1 criteria provided, single submitter clinical testing The missense variant p.Y230C in HSD3B7 (NM_025193.3) has been reported in compound heterozygous state with another missense variant in a patient evaluated for bile acid synthesis disorders (Al-Hussaini AA et al,2017). Functional analysis has not been performed for the variant. The p.Y230C variant is observed in 2/30,500 (0.0066%) alleles from individuals of South Asian background in gnomAD Exomes and is novel (not in any individuals) in 1000 Genomes. The p.Y230C missense variant is predicted to be damaging by both SIFT and PolyPhen2. The tyrosine residue at codon 230 of HSD3B7 is conserved in all mammalian species. The nucleotide c.689 in HSD3B7 is predicted conserved by GERP++ and PhyloP across 100 vertebrates. Since the variant has been previously reported in a patient with a similar presentation and has been detected in both affected individuals in this family, it has been classified as Uncertain Significance.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.